高级检索
当前位置: 首页 > 详情页

Tc-99m-3P-RGD2 molecular imaging targeting integrin alpha (v) beta (3) in head and neck squamous cancer xenograft

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Nuclear Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China [2]Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China [3]Cardiovascular Institute & Fu Wai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100037, China [4]State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100050, China
出处:
ISSN:

关键词: Head and neck squamous cell carcinoma Integrin alpha(v)beta(3) Molecular imaging Tc-99m-3P-RGD2 Angiogenesis

摘要:
Tc-99m-3P-RGD2 and SPECT/CT were valuable tools for selecting patient likely benefit from integrin alpha (v) beta (3) blocking therapy. To evaluate the feasibility of Tc-99m-3P-RGD2 imaging to detect head and neck squamous cell carcinoma, Tc-99m-3P-RGD2 was prepared and the relationship between its accumulation and integrin alpha (v) beta (3) expression in nude mice bearing HEP-2 or CNE-1 carcinoma xenograft were analyzed. This study demonstrated that Tc-99m-3P-RGD2, with high affinity to integrin alpha (v) beta (3), will provide basis for alpha (v) beta (3) involved individual therapy.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 4 区 化学
小类 | 2 区 核科学技术 4 区 分析化学 4 区 无机化学与核化学
最新[2025]版:
大类 | 3 区 化学
小类 | 3 区 无机化学与核化学 4 区 分析化学 4 区 核科学技术
JCR分区:
出版当年[2013]版:
Q1 NUCLEAR SCIENCE & TECHNOLOGY Q3 CHEMISTRY, ANALYTICAL Q3 CHEMISTRY, INORGANIC & NUCLEAR
最新[2024]版:
Q3 CHEMISTRY, INORGANIC & NUCLEAR Q3 NUCLEAR SCIENCE & TECHNOLOGY Q4 CHEMISTRY, ANALYTICAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Department of Nuclear Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
通讯作者:
通讯机构: [2]Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:28514 今日访问量:0 总访问量:1589 更新日期:2025-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)